Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) P/S ratio
As of 25 September 2026, Medtronic PLC (MDT) trades at a P/S ratio of 3.0×. Over the past ten years it has ranged from 2.6× (June 2026) to 6.3× (April 2021); the current reading is higher than 3% of that period. That is above the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2026 | 2.9× | (12.16%) |
| FY2025 | 3.2× | (1.29%) |
| FY2024 | 3.3× | (14.76%) |
| FY2023 | 3.9× | (11.63%) |
| FY2022 | 4.4× | (25.26%) |
| FY2021 | 5.8× | 29.14% |
| FY2020 | 4.5× | 15.69% |
| FY2019 | 3.9× | 7.82% |
| FY2018 | 3.6× | (6.62%) |
| FY2017 | 3.9× | 0.19% |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jul 2026 | 2.9× | 1.99% |
| Apr 2026 | 2.9× | (23.12%) |
| Jan 2026 | 3.7× | 10.98% |
| Oct 2025 | 3.3× | (1.07%) |
| 43 more quarters | Free account |
Against its own ten years
Low 2.6×
High 6.3×
Ten-year median
3.9×
Current reading's percentile
3
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.2× |
| GEHC GE HealthCare Technologies Inc. compare | 1.4× |
| MDT Medtronic PLC | 3.0× |
| BSX Boston Scientific Corporation compare | 3.1× |
| STE STERIS plc compare | 3.4× |
| ABT Abbott Laboratories compare | 3.8× |
| SYK Stryker Corporation compare | 4.0× |
| DXCM DexCom, Inc. compare | 6.7× |
| EW Edwards Lifesciences Corporation compare | 7.6× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement